C5ORF13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.776200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.859600E-01
Normal-vs-Stage2
2.982800E-01
Normal-vs-Stage3
5.451600E-01
Normal-vs-Stage4
9.485000E-01
Stage1-vs-Stage2
4.132800E-01
Stage1-vs-Stage3
7.899400E-01
Stage1-vs-Stage4
5.994300E-02
Stage2-vs-Stage3
7.691400E-01
Stage2-vs-Stage4
1.720250E-01
Stage3-vs-Stage4
3.392000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.508600E-01
Normal-vs-AfricanAmerican
3.625000E-01
Normal-vs-Asian
6.174200E-01
Caucasian-vs-AfricanAmerican
6.865200E-01
Caucasian-vs-Asian
4.634800E-01
AfricanAmerican-vs-Asian
4.786400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.869600E-01
Normal-vs-Female
6.396400E-01
Male-vs-Female
6.659800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.344000E-01
Normal-vs-Age(41-60Yrs)
7.393000E-01
Normal-vs-Age(61-80Yrs)
2.539800E-01
Normal-vs-Age(81-100Yrs)
2.619400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.860000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.368600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.307200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.784200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.293790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.161600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.059400E-01
Normal-vs-Daily Drinker
4.992000E-01
Normal-vs-Weekly Drinker
7.016200E-01
Normal-vs-Occasional Drinker
5.097000E-01
Normal-vs-Social Drinker
6.709200E-01
Non Drinker-vs-Daily Drinker
7.233200E-01
Non Drinker-vs-Weekly Drinker
1.127620E-01
Non Drinker-vs-Occasional Drinker
4.525400E-01
Non Drinker-vs-Social Drinker
3.591200E-01
Daily Drinker-vs-Weekly Drinker
5.576300E-02
Daily Drinker-vs-Occasional Drinker
3.388800E-01
Daily Drinker-vs-Social Drinker
1.906770E-01
Weekly Drinker-vs-Occasional Drinker
5.254000E-01
Weekly Drinker-vs-Social Drinker
4.752400E-01
Occasional Drinker-vs-Social Drinker
9.580800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.745400E-01
Normal-vs-Grade 2
2.051400E-01
Normal-vs-Grade 3
4.264200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.033800E-04
Grade 1-vs-Grade 3
5.994500E-02
Grade 1-vs-Grade 4
7.745400E-01
Grade 2-vs-Grade 3
1.940150E-01
Grade 2-vs-Grade 4
2.051400E-01
Grade 3-vs-Grade 4
4.264200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.642200E-01
Normal-vs-NonDiabetic
3.179000E-01
Diabetic-vs-NonDiabetic
4.602400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.463000E-01
Normal-vs-NoPancreatitis
3.078000E-01
Pancreatitis-vs-NoPancreatitis
5.808400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.322000E-01
Normal-vs-N1
3.378200E-01
N0-vs-N1
3.429400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.790600E-01
Normal-vs-TP53-NonMutant
1.210840E-01
TP53-Mutant-vs-TP53-NonMutant
3.600500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
